Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
NCT02448641
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
163
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Ischemic Stroke
Interventions
BIOLOGICAL:
SB623 Implant (2.5M)
BIOLOGICAL:
SB623 Implant (5.0M)
PROCEDURE:
Sham surgery
Sponsor
SanBio, Inc.
Collaborators
[object Object]